Breast Cancer Clinical Trial

Body Composition and White Adipose Tissue Inflammation

Summary

The investigators want to find a better way to predict the risk of having fatty tissue inflammation by using a different approach to finding out body fat composition. In this study, the investigators want to estimate the body fat composition using a DEXA scan. DEXA stands for dual energy X-ray absorptiometry. It is the standard and established test to determine bone mineral density (how strong the bones are) to diagnose osteoporosis. This test can also be used to determine the body composition including percent body fat and lean mass. The investigators will compare the participants DEXA scan results for body fat composition to the inflammation found in the breast tissue from the mastectomy to see if there is a relationship. If successful, this may help us predict which patients may be at risk for breast cancer in the future. In addition, the investigators will compare the participants DEXA scan results for body fat composition and inflammation found in the fat tissue from the mastectomy or prostatectomy to the level of exercise activity as measured by a short questionnaire to see if there is a relationship. The investigators will also measure the participants waist to hip ratio.

Finally, at the time the participant has blood drawn for their standard presurgical testing, the investigators will also test the blood for prediabetes using a blood test called hemoglocin A1c. The investigators will also measure for the participants waist to hip ratio, and a Hgb A1c blood drawn will be take at the time of presurgical testing. If not feasible, Hgb A1c can be drawn at a separate visit prior to the DEXA scan. If successful, this may help us predict which patients may be at risk for breast cancer in the future.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18
Female
All BMIs
Patients undergoing mastectomy at MSKCC (i.e. Nipple-sparing mastectomy, skin-sparing mastectomy, simple mastectomy, modified radical mastectomy, radical mastectomy); mastectomy may be either prophylactic or therapeutic. OR
Patients undergoing hysterectomy at MSKCC
History of prior breast surgeries/procedures is acceptable

Exclusion Criteria:

Pregnancy (confirmed or suspected);
Inability to lay supine on equipment table and maintain the position for the necessary time;
Weight superior to the maximum allowed by the DEXA machine (over 350 lbs or 158 kg);
Greater than 10% baseline weight loss in the past year;
Planned surgical procedure is not a Mastectomy (i.e. breast conservation surgery or other non-mastectomy procedure; such as lumpectomy) or hysterectomy
Metastatic cancer
History of Wasting Syndromes or Cachexia
Use of daily NSAIDs, aspirin, or steroids (other than inhaled or topical) within 30 days of surgery
Use of neoadjuvant systemic or radiation therapy.

Study is for people with:

Breast Cancer

Estimated Enrollment:

202

Study ID:

NCT02713022

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Waters Corporation (Data Analysis Only)
Milford Massachusetts, 01757, United States
Memoral Sloan Kettering Cancer Center (Consent Only)
Basking Ridge New Jersey, , United States
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Consent only)
Montvale New Jersey, 07645, United States
Memorial Sloan Kettering Cancer Center @ Commack (Consent Only)
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester (Consent Only)
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Memorial Sloan Kettering Nassau (Consent only)
Uniondale New York, 11553, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

202

Study ID:

NCT02713022

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.